Alder Biopharmaceuticals, Inc.
Biopharmaceutical company raises $11.1M in series A financing
Published in Lab Business Week, September 18th, 2005
Sevin Rosen Funds led the $11.1 million round and was joined by Ventures West, WRF Capital and other private investors.
"This financing is proof that the investment community is recognizing the value of our technologies and their enormous potential within the field of antibody therapeutics," said Randall Schatzman, CEO and an Alder founder. "This funding will allow us to develop our lead antibody therapeutic, broaden our product pipeline, and build on our proprietary antibody discovery and manufacturing technologies."
Alder's proprietary technologies...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-09-18)
More Articles from Lab Business Week
- Access Pharmaceuticals, Inc.
Pharmaceutical company announces financing arrangement - Actavis
Pharma company appoints chief executive of finance - Acusphere, Inc.
Pharmaceutical firm spends $8.4M to build out facility for drug manufacturing - Adherex Technologies, Inc.
Pharmaceutical firm reports loss of $0.13 per share - Adventrx Pharmaceuticals, Inc.
Pharmaceutical firm posts loss of $0.06 per share - Allos Therapeutics, Inc.
Biopharmaceutical firm reports loss of $0.13 per share - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
